169 related articles for article (PubMed ID: 8055109)
1. CD30 antigen in non-Hodgkin's lymphoma.
Miyake K; Yoshino T; Sarker AB; Teramoto N; Akagi T
Pathol Int; 1994 Jun; 44(6):428-34. PubMed ID: 8055109
[TBL] [Abstract][Full Text] [Related]
2. Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency.
Kanavaros P; Jiwa M; van der Valk P; Walboomers J; Horstman A; Meijer CJ
Hum Pathol; 1993 Jul; 24(7):725-9. PubMed ID: 8100553
[TBL] [Abstract][Full Text] [Related]
3. CD30 differential staining is useful in classifying lymphomas intermediate between Hodgkin's disease and anaplastic large cell (Ki1) lymphoma.
Schmidt U; Metz KA; Möser U
Tumori; 1998; 84(6):695-700. PubMed ID: 10080680
[TBL] [Abstract][Full Text] [Related]
4. Primary cutaneous Ki-1(CD30) positive anaplastic large cell lymphoma in childhood.
Tomaszewski MM; Moad JC; Lupton GP
J Am Acad Dermatol; 1999 May; 40(5 Pt 2):857-61. PubMed ID: 10321635
[TBL] [Abstract][Full Text] [Related]
5. Primary gastric CD30 (Ki-1)-positive large cell non-Hodgkin's lymphomas. A clinicopathologic analysis of six cases.
Paulli M; Rosso R; Kindl S; Boveri E; Bonoldi E; Stracca V; Motta T; Arrigoni G; Lazzarino M; Menestrina F
Cancer; 1994 Feb; 73(3):541-9. PubMed ID: 8299075
[TBL] [Abstract][Full Text] [Related]
6. CD30 expression in non-Hodgkin's lymphoma.
Piris M; Brown DC; Gatter KC; Mason DY
Histopathology; 1990 Sep; 17(3):211-8. PubMed ID: 2173674
[TBL] [Abstract][Full Text] [Related]
7. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
Miettinen M
Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemistry of Hodgkin and non-Hodgkin lymphomas with emphasis on the diagnostic significance of the BNH9 antibody reactivity with anaplastic large cell (CD30 positive) lymphomas.
Carbone A; Gloghini A; Volpe R
Cancer; 1992 Dec; 70(11):2691-8. PubMed ID: 1330287
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Bar virus and progression of non-Hodgkin's lymphoma to Ki-1-positive, anaplastic large cell phenotype.
DiGiuseppe JA; Wu TC; Zehnbauer BA; McDowell PR; Barletta JM; Ambinder RF; Mann RB
Mod Pathol; 1995 Jun; 8(5):553-9. PubMed ID: 7675777
[TBL] [Abstract][Full Text] [Related]
10. Anaplastic large cell (CD30/Ki-1+) lymphoma in HIV+ patients: clinical and pathological findings in a group of ten patients.
Nosari A; Cantoni S; Oreste P; Schiantarelli C; Landonio G; Alexiadis S; Gargantini L; Caggese L; Gambacorta M; Morra E
Br J Haematol; 1996 Dec; 95(3):508-12. PubMed ID: 8943892
[TBL] [Abstract][Full Text] [Related]
11. [Dipeptidyl aminopeptidase-IV as a histochemical marker of differential diagnosis of large cell anaplastic CD30+-lymphoma and Hodgkin's disease].
Raĭkhlin NT; Bukaeva IA; Probatova NA; Smirnova EA; Pavlovskaia AI; Tupitsyn NN; Sholokhova EN
Arkh Patol; 2000; 62(4):3-8. PubMed ID: 10971865
[TBL] [Abstract][Full Text] [Related]
12. Immunophenotypic and molecular analyses of acquired immune deficiency syndrome-related and Epstein-Barr virus-associated lymphomas: a comparative study.
Carbone A; Dolcetti R; Gloghini A; Maestro R; Vaccher E; di Luca D; Tirelli U; Boiocchi M
Hum Pathol; 1996 Feb; 27(2):133-46. PubMed ID: 8617454
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of thymus and activation regulated chemokine and its receptor CCR4 in nodal and cutaneous anaplastic large-cell lymphomas and Hodgkin's disease.
Vermeer MH; Dukers DF; ten Berge RL; Bloemena E; Wu L; Vos W; de Vries E; Tensen CP; Meijer CJ; Willemze R
Mod Pathol; 2002 Aug; 15(8):838-44. PubMed ID: 12181269
[TBL] [Abstract][Full Text] [Related]
14. Cellular kinetic differences between Hodgkin's and anaplastic large cell lymphomas: relation to the expression of p34cdc2 and cyclin B-1.
Leoncini L; Megha T; Lazzi S; Bellan C; Luzi P; Tosi P; Cevenini G; Barbini P; Ascani S; Briskomatis A; Pileri S; Kraft R; Laissue JA; Cottier H
Int J Cancer; 1998 Jul; 77(3):408-14. PubMed ID: 9663604
[TBL] [Abstract][Full Text] [Related]
15. CD26/dipeptidyl peptidase IV expression in human lymphomas is restricted to CD30-positive anaplastic large cell and a subset of T-cell non-Hodgkin's lymphomas.
Carbone A; Cozzi M; Gloghini A; Pinto A
Hum Pathol; 1994 Dec; 25(12):1360-5. PubMed ID: 8001932
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory malignant fibrous histiocytoma: distinction from Hodgkin's disease and non-Hodgkin's lymphoma by a panel of leukocyte markers.
Khalidi HS; Singleton TP; Weiss SW
Mod Pathol; 1997 May; 10(5):438-42. PubMed ID: 9160307
[TBL] [Abstract][Full Text] [Related]
17. CD30 antigen expression in florid immunoblastic proliferations. A clinicopathologic study of 14 cases.
Segal GH; Kjeldsberg CR; Smith GP; Perkins SL
Am J Clin Pathol; 1994 Sep; 102(3):292-8. PubMed ID: 8085551
[TBL] [Abstract][Full Text] [Related]
18. Morphology in Ki-1(CD30)-positive non-Hodgkin's lymphoma is correlated with clinical features and the presence of a unique chromosomal abnormality, t(2;5)(p23;q35).
Bitter MA; Franklin WA; Larson RA; McKeithan TW; Rubin CM; Le Beau MM; Stephens JK; Vardiman JW
Am J Surg Pathol; 1990 Apr; 14(4):305-16. PubMed ID: 2157342
[TBL] [Abstract][Full Text] [Related]
19. Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression.
Kanavaros P; Boulland ML; Petit B; Arnulf B; Gaulard P
Leuk Lymphoma; 2000 Jul; 38(3-4):317-26. PubMed ID: 10830738
[TBL] [Abstract][Full Text] [Related]
20. Paraffin section immunohistochemistry in the diagnosis of Hodgkin's disease and anaplastic large cell (CD30+) lymphomas.
Carbone A; Gloghini A; Volpe R
Virchows Arch A Pathol Anat Histopathol; 1992; 420(6):527-32. PubMed ID: 1376944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
